Glaukos (GKOS) News Today $126.03 -31.33 (-19.91%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$124.62 -1.41 (-1.12%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Glaukos (NYSE:GKOS) Price Target Raised to $176.00February 24 at 2:07 AM | americanbankingnews.comWe're Not Worried About Glaukos' (NYSE:GKOS) Cash BurnFebruary 23 at 11:07 AM | finance.yahoo.comWells Fargo & Company Increases Glaukos (NYSE:GKOS) Price Target to $160.00February 23 at 3:35 AM | americanbankingnews.comGlaukos (NYSE:GKOS) Shares Gap Down Following Weak EarningsGlaukos (NYSE:GKOS) Shares Gap Down on Disappointing EarningsFebruary 22 at 10:31 AM | marketbeat.comWells Fargo & Company Forecasts Strong Price Appreciation for Glaukos (NYSE:GKOS) StockWells Fargo & Company boosted their price objective on Glaukos from $153.00 to $160.00 and gave the stock an "overweight" rating in a report on Friday.February 22 at 9:40 AM | marketbeat.comNeedham & Company LLC Forecasts Strong Price Appreciation for Glaukos (NYSE:GKOS) StockNeedham & Company LLC raised their price objective on shares of Glaukos from $149.00 to $176.00 and gave the company a "buy" rating in a research note on Friday.February 22 at 8:15 AM | marketbeat.comGlaukos price target raised to $176 from $149 at NeedhamFebruary 22 at 7:35 AM | markets.businessinsider.comPrincipal Financial Group Inc. Trims Stock Position in Glaukos Co. (NYSE:GKOS)Principal Financial Group Inc. lessened its stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 6.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 268,534 shares of the medical instruments supplier's stock after selliFebruary 22 at 3:39 AM | marketbeat.comGlaukos price target raised to $160 from $153 at Wells FargoFebruary 22 at 2:34 AM | markets.businessinsider.comGlaukos (NYSE:GKOS) Shares Gap Down on Disappointing EarningsFebruary 22 at 1:53 AM | americanbankingnews.comGlaukos (NYSE:GKOS) Announces Quarterly Earnings Results, Misses Expectations By $0.02 EPSGlaukos (NYSE:GKOS - Get Free Report) released its quarterly earnings data on Thursday. The medical instruments supplier reported ($0.40) EPS for the quarter, missing analysts' consensus estimates of ($0.38) by ($0.02). Glaukos had a negative return on equity of 18.99% and a negative net margin of 42.43%.February 21 at 5:07 PM | marketbeat.comGlaukos Corporation (GKOS) Q4 2024 Earnings Call TranscriptFebruary 21 at 5:03 AM | seekingalpha.comGlaukos down 14% at $135 after Q4 results and guidanceFebruary 21 at 1:37 AM | markets.businessinsider.comGlaukos (GKOS) Receives a Buy from BTIGFebruary 21 at 1:37 AM | markets.businessinsider.comGlaukos reports Q4 EPS (40c), consensus (39c)February 20, 2025 | markets.businessinsider.comInsider Selling: Glaukos Co. (NYSE:GKOS) Insider Sells 3,416 Shares of StockGlaukos Co. (NYSE:GKOS - Get Free Report) insider Tomas Navratil sold 3,416 shares of the stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $147.14, for a total value of $502,630.24. Following the completion of the sale, the insider now directly owns 72,437 shares of the company's stock, valued at $10,658,380.18. The trade was a 4.50 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.February 20, 2025 | marketbeat.comGlaukos Announces Fourth Quarter and Full Year 2024 Financial ResultsFebruary 20, 2025 | businesswire.comMizuho Upgrades Glaukos (GKOS)February 20, 2025 | msn.comWhat To Expect From Glaukos Corp (GKOS) Q4 2024 EarningsFebruary 20, 2025 | finance.yahoo.comGlaukos (NYSE:GKOS) Upgraded by Mizuho to Outperform RatingMizuho raised shares of Glaukos from a "neutral" rating to an "outperform" rating and raised their target price for the company from $140.00 to $200.00 in a report on Wednesday.February 20, 2025 | marketbeat.comTomas Navratil Sells 3,416 Shares of Glaukos Co. (NYSE:GKOS) StockFebruary 20, 2025 | insidertrades.comGlaukos Co. (NYSE:GKOS) Shares Sold by New York State Common Retirement FundNew York State Common Retirement Fund decreased its holdings in Glaukos Co. (NYSE:GKOS - Free Report) by 3.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 381,288 shares of the medical instruments supFebruary 20, 2025 | marketbeat.comPeregrine Capital Management LLC Lowers Stock Position in Glaukos Co. (NYSE:GKOS)Peregrine Capital Management LLC reduced its position in Glaukos Co. (NYSE:GKOS - Free Report) by 97.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,641 shares of the medical instruments supplier's stock after selling 58,3February 20, 2025 | marketbeat.comMizuho Upgrades Glaukos (NYSE:GKOS) to OutperformFebruary 20, 2025 | americanbankingnews.comMizuho upgrades Glaukos to Outperform on ‘bullish’ iDose checksFebruary 19, 2025 | markets.businessinsider.comGlaukos upgraded to Outperform from Neutral at MizuhoFebruary 19, 2025 | markets.businessinsider.comTruist maintains Buy on Glaukos stock with $185 targetFebruary 17, 2025 | msn.comTruist Financial Remains a Buy on Glaukos (GKOS)February 14, 2025 | markets.businessinsider.comGlaukos Co. (NYSE:GKOS) Shares Sold by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC decreased its stake in Glaukos Co. (NYSE:GKOS - Free Report) by 12.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 342,493 shares of the medical instrumFebruary 14, 2025 | marketbeat.comLegato Capital Management LLC Has $1.41 Million Holdings in Glaukos Co. (NYSE:GKOS)Legato Capital Management LLC grew its position in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 85.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 9,381 shares of the medical instruments supplier's stock after purchasing an additionalFebruary 13, 2025 | marketbeat.comGlaukos Co. (NYSE:GKOS) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of Glaukos Co. (NYSE:GKOS - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the thirteen ratings firms that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, one has issued a hold rating, ten have assignFebruary 13, 2025 | marketbeat.comGlaukos (GKOS) Expected to Announce Earnings on ThursdayGlaukos (NYSE:GKOS) will be releasing earnings after the market closes on Thursday, February 20, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=658676)February 13, 2025 | marketbeat.comGlaukos Co. (NYSE:GKOS) Shares Sold by Trust Point Inc.Trust Point Inc. reduced its stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 42.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,480 shares of the medical instruments suppFebruary 5, 2025 | marketbeat.comGlaukos Co. (NYSE:GKOS) Short Interest Up 18.3% in JanuaryGlaukos Co. (NYSE:GKOS - Get Free Report) was the target of a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 3,040,000 shares, a growth of 18.3% from the December 31st total of 2,570,000 shares. Based on an average trading volume of 567,300 shares, the short-interest ratio is currently 5.4 days.February 2, 2025 | marketbeat.comGlaukos Corporation's (NYSE:GKOS) Intrinsic Value Is Potentially 90% Above Its Share PriceFebruary 1, 2025 | finance.yahoo.comPiper Sandler Sticks to Their Buy Rating for Glaukos (GKOS)January 27, 2025 | markets.businessinsider.comGlaukos price target raised to $180 from $140 at Piper SandlerJanuary 27, 2025 | markets.businessinsider.comPiper Sandler raises Glaukos stock target to $180, keeps overweightJanuary 27, 2025 | msn.comGlaukos (NYSE:GKOS) Earns "Overweight" Rating from Piper SandlerPiper Sandler reiterated an "overweight" rating and issued a $180.00 price objective (up from $140.00) on shares of Glaukos in a research report on Monday.January 27, 2025 | marketbeat.comAvior Wealth Management LLC Purchases New Stake in Glaukos Co. (NYSE:GKOS)Avior Wealth Management LLC acquired a new position in shares of Glaukos Co. (NYSE:GKOS - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,602 shares of the medical instrumentsJanuary 27, 2025 | marketbeat.com$1000 Invested In Glaukos 5 Years Ago Would Be Worth This Much TodayJanuary 24, 2025 | benzinga.comZweig DiMenna Associates LLC Takes $8.80 Million Position in Glaukos Co. (NYSE:GKOS)Zweig DiMenna Associates LLC acquired a new position in shares of Glaukos Co. (NYSE:GKOS - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 58,665 shares of the medical instruments supplier'sJanuary 24, 2025 | marketbeat.comGlaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20January 23, 2025 | finance.yahoo.comGlaukos Co. (NYSE:GKOS) Shares Sold by Riverbridge Partners LLCRiverbridge Partners LLC cut its stake in Glaukos Co. (NYSE:GKOS - Free Report) by 34.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 312,931 shares of the medical instruments supplier'sJanuary 23, 2025 | marketbeat.comGlaukos (NYSE:GKOS) Reaches New 12-Month High - What's Next?Glaukos (NYSE:GKOS) Hits New 1-Year High - Here's What HappenedJanuary 21, 2025 | marketbeat.comGlaukos stock soars to all-time high, reaches $161.17January 21, 2025 | msn.comAssenagon Asset Management S.A. Decreases Stock Position in Glaukos Co. (NYSE:GKOS)Assenagon Asset Management S.A. trimmed its position in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 24.8% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 56,984 shares of the medical instruments supplier's stock after selling 18,814January 20, 2025 | marketbeat.comGlaukos Co. (NYSE:GKOS) Short Interest UpdateGlaukos Co. (NYSE:GKOS - Get Free Report) was the target of a significant growth in short interest in December. As of December 31st, there was short interest totalling 3,040,000 shares, a growth of 18.3% from the December 15th total of 2,570,000 shares. Based on an average daily volume of 567,300 shares, the days-to-cover ratio is currently 5.4 days.January 19, 2025 | marketbeat.comOak Ridge Investments LLC Acquires Shares of 11,150 Glaukos Co. (NYSE:GKOS)Oak Ridge Investments LLC acquired a new stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 11,150 shares of the medical instruments supplier's stock, valued atJanuary 19, 2025 | marketbeat.comGlaukos Co. (NYSE:GKOS) Given Average Rating of "Moderate Buy" by AnalystsShares of Glaukos Co. (NYSE:GKOS - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the thirteen brokerages that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has issued aJanuary 19, 2025 | marketbeat.com Get Glaukos News Delivered to You Automatically Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter. Email Address GKOS Media Mentions By Week GKOS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GKOS News Sentiment▼0.240.60▲Average Medical News Sentiment GKOS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GKOS Articles This Week▼327▲GKOS Articles Average Week Get Glaukos News Delivered to You Automatically Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PHG News ZBH News SOLV News SNN News PEN News STVN News BLCO News INSP News NARI News NVST News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GKOS) was last updated on 2/24/2025 by MarketBeat.com Staff From Our PartnersMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredShocking new Trump video releasedThe 10 Stocks Guaranteed To Boom With Trump Back In Office I’m not talking about Tesla or Palantir… Trum...Porter & Company | SponsoredIgnore Fox Business’s “man who calls it all” at your perilThis is the biggest AI investment story you’ve never been told… and people who invest before March 19 could st...The Oxford Club | SponsoredThis Crypto Is Set to Explode in FebruaryA little-known IRS loophole has been gaining serious attention... If you have a retirement account, you can...Premier Gold Co | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Glaukos Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Glaukos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GKOS Stock Alerts